Dennis E. Hruby
52Patents
8h-index
35Co-inventors
78Inventor score
Filing activity: Mar 3, 1994 → Jul 14, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5821088A | Use of gram-positive bacteria to express recombinant proteins | Chemistry; Metallurgy | 56 | Expired |
| US8993604B2 | Treatment and prevention of dengue virus infections | Physics | 51 | Active |
| US7994221B2 | Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses | Emerging Cross-Sectional Technologies | 23 | Active |
| US9029376B2 | Small molecule inhibitors for the treatment or prevention of dengue virus infection | Emerging Cross-Sectional Technologies | 20 | Active |
| US5985654A | Recombinant poxvirus and streptococcal M protein vaccine | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6306619A | DegP periplasmic protease a new anti-infective target and an in vitro assay for DegP protease function | Physics | 15 | Expired |
| US7872037B2 | Antiviral drugs for treatment of arenavirus infection | Emerging Cross-Sectional Technologies | 11 | Active |
| US9353051B2 | Antiviral drugs for treatment or prevention of dengue infection | Emerging Cross-Sectional Technologies | 10 | Active |
| US7067248B2 | Screening method for orthopoxvirus antivirals | Physics | 4 | Expired |
| US8410149B2 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses | Emerging Cross-Sectional Technologies | 2 | Active |
| US8664274B2 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses | Emerging Cross-Sectional Technologies | 2 | Active |
| US8629170B2 | Anti-viral drugs for treatment of arenavirus infection | Emerging Cross-Sectional Technologies | 2 | Active |
| US8461177B2 | Antiviral drugs for treatment of arenavirus infection | Chemistry; Metallurgy | 2 | Active |
| US9907859B2 | ST-246 liquid formulations and methods | Chemistry; Metallurgy | 1 | Active |
| US7977365B2 | Antiviral drugs for treatment of arenavirus infection | Emerging Cross-Sectional Technologies | 1 | Active |
| US9301949B2 | Thienopyridine derivatives for the treatment and prevention of dengue virus infections | Emerging Cross-Sectional Technologies | 1 | Active |
| US10864282B2 | ST-246 liquid formulations and methods | Chemistry; Metallurgy | 1 | Active |
| US8148428B2 | Antiviral drugs for treatment of arenavirus infection | Emerging Cross-Sectional Technologies | 1 | Active |
| US9339466B2 | Polymorphic forms of ST-246 and methods of preparation | Chemistry; Metallurgy | 1 | Active |
| US8492434B2 | Antiviral drugs for treatment of arenavirus infection | Emerging Cross-Sectional Technologies | 1 | Active |
| US8658697B2 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses | Emerging Cross-Sectional Technologies | 1 | Active |
| US11433051B2 | ST-246 (tecovirimat monohydrate) suspension formulations | Human Necessities | 1 | Active |
| US9115065B2 | Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses | Emerging Cross-Sectional Technologies | 0 | Active |
| US10716759B2 | Rehydration of micronized tecovirimat monohydrate | Human Necessities | 0 | Active |
| US9096597B2 | Antiviral drugs for treatment of Arenavirus infection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.